Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder.

Current opinion in nephrology and hypertension - 1 May 2013

Kopp Jeffrey B

Abstract excerpt

PURPOSE OF REVIEW: Hypertension is the attributed cause of approximately 30% of end-stage kidney disease cases in the United States, but there has been controversy as to whether benign hypertension is a cause of chronic kidney disease. RECENT FINDINGS: The histology of chronic kidney disease attributed to nonmalignant hypertension is arterionephrosclerosis, with pathology in the terminal branches of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein L1
Share to Apolipoproteins
Share to Hypertension, Renal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation Mediators

Share to Lipoproteins, HDL

Share to Nephritis

Share to Racial Groups

Share to Renal Insufficiency, Chronic

Source

Open in PubMed Open full text

Identifiers

PMID: 23470819
DOI: 10.1097/MNH.0b013e3283600f8c
PMCID: PMC4165431

Genes

APOL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder.PMID 23470819Read ↗

Target organ damage in African American hypertension: role of APOL1.Semantic proximity Read ↗

The Apolipoprotein L1 Gene and Cardiovascular Disease.Semantic proximity Read ↗

Apolipoprotein L1 (APOL1) and Nephropathy.Semantic proximity Read ↗

The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.Semantic proximity Read ↗

Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.Semantic proximity Read ↗

Apolipoprotein L1 nephropathies: 2017 in review.Semantic proximity Read ↗

A perspective on arterionephrosclerosis: from pathology to potential pathogenesis.Semantic proximity Read ↗

Genetics, Genomics, and Precision Medicine in End-Stage Kidney Disease.Semantic proximity Read ↗

Molecular Mechanisms of APOL1-Associated Kidney Disease.Semantic proximity Read ↗

APOL1 localization in normal kidney and nondiabetic kidney disease.Semantic proximity Read ↗

APOL1 Nephropathy: From Genetics to Clinical Applications.Semantic proximity Read ↗

Beyond Blood Pressure: Emerging Pathways and Precision Approaches in Hypertension-Induced Kidney DamageSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.